https://preview.xbpnews.com/unitedhealth-group-incorporated-unh-analyst-upgrade-sets-buy-rating-with-an-eye-on-450-target Stocks Telegraph en 2026-06-04 UnitedHealth Group Incorporated (UNH): Analyst Upgrade Sets Buy Rating with an Eye on $450 Target https://preview.xbpnews.com/pvh-corp-pvh-in-line-rating-amid-price-volatility-suggests-caution-for-investors Stocks Telegraph en 2026-06-04 PVH Corp. (PVH): In-Line Rating Amid Price Volatility Suggests Caution for Investors https://preview.xbpnews.com/ollies-bargain-outlet-holdings-inc-olli-accumulate-rating-signals-upside-potential Stocks Telegraph en 2026-06-04 Ollie’s Bargain Outlet Holdings, Inc. (OLLI): Accumulate Rating Signals Upside Potential https://preview.xbpnews.com/murphy-oil-corporation-mur-receives-overweight-rating-from-keybanc-with-promising-upside-potential Stocks Telegraph en 2026-06-04 Murphy Oil Corporation (MUR) Receives Overweight Rating from KeyBanc with Promising Upside Potential https://preview.xbpnews.com/medtronic-plc-mdt-receives-buy-rating-from-btig-upholding-investor-optimism Stocks Telegraph en 2026-06-04 Medtronic plc (MDT) Receives Buy Rating from BTIG: Upholding Investor Optimism https://preview.xbpnews.com/erasca-inc-eras-receives-neutral-rating-amid-market-volatility-potential-upside-remains Stocks Telegraph en 2026-06-04 Erasca, Inc. (ERAS) Receives Neutral Rating Amid Market Volatility: Potential Upside Remains https://preview.xbpnews.com/commercial-metals-company-cmc-rating-update-reveals-equal-weight-prospects-amid-mixed-earnings Stocks Telegraph en 2026-06-04 Commercial Metals Company (CMC): Rating Update Reveals Equal-Weight Prospects Amid Mixed Earnings https://preview.xbpnews.com/anterix-inc-atex-receives-a-neutral-rating-from-b-riley-short-term-upside-potential-remains Stocks Telegraph en 2026-06-04 Anterix Inc. (ATEX) Receives a Neutral Rating from B. Riley; Short-Term Upside Potential Remains https://preview.xbpnews.com/adc-therapeutics-s-a-adct-receives-sector-perform-rating-amid-market-struggles Stocks Telegraph en 2026-06-04 ADC Therapeutics S.A. (ADCT) Receives Sector Perform Rating Amid Market Struggles https://preview.xbpnews.com/yum-brands-inc-yum-upgraded-to-overweight-by-morgan-stanley-amid-positive-earnings-surprise Stocks Telegraph en 2026-06-03 Yum! Brands, Inc. (YUM) Upgraded to Overweight by Morgan Stanley Amid Positive Earnings Surprise https://preview.xbpnews.com/ssr-mining-inc-ssrm-analyst-upgrade-sparks-optimism-as-price-target-reaches-40 Stocks Telegraph en 2026-06-03 SSR Mining Inc. (SSRM): Analyst Upgrade Sparks Optimism as Price Target Reaches $40 https://preview.xbpnews.com/rezolute-inc-rzlt-receives-market-outperform-rating-analysts-see-significant-upside Stocks Telegraph en 2026-06-03 Rezolute, Inc. (RZLT) Receives Market Outperform Rating, Analysts See Significant Upside https://preview.xbpnews.com/aveanna-healthcare-holdings-inc-avah-receives-outperform-rating-with-upside-potential Stocks Telegraph en 2026-06-03 Aveanna Healthcare Holdings Inc. (AVAH) Receives Outperform Rating with Upside Potential https://preview.xbpnews.com/acadia-healthcare-company-inc-achc-analyst-upgrade-signals-potential-recovery-ahead Stocks Telegraph en 2026-06-03 Acadia Healthcare Company, Inc. (ACHC): Analyst Upgrade Signals Potential Recovery Ahead https://preview.xbpnews.com/3-stocks-showing-early-price-action-p3-health-partners-piii-sintx-technologies-sint-cardiol-therapeutics-crdl Stocks Telegraph en 2026-06-03 3 Stocks Showing Early Price Action: P3 Health Partners (PIII), SINTX Technologies (SINT), Cardiol Therapeutics (CRDL) https://preview.xbpnews.com/3-stocks-that-could-see-trading-interest-vivos-therapeutics-vvos-cardiol-therapeutics-crdl-dare-bioscience-dare Stocks Telegraph en 2026-06-03 3 Stocks That Could See Trading Interest: Vivos Therapeutics (VVOS), Cardiol Therapeutics (CRDL), Dare Bioscience (DARE) https://preview.xbpnews.com/3-stocks-that-could-get-active-cardiol-therapeutics-crdl-silexion-therapeutics-slxn-can-fite-biopharma-canf Stocks Telegraph en 2026-06-03 3 Stocks That Could Get Active: Cardiol Therapeutics (CRDL), Silexion Therapeutics (SLXN), Can-Fite Biopharma (CANF)